ClariVest Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-203,053
Closed -$12.5M 702
2015
Q4
$12.5M Sell
203,053
-2,300
-1% -$145K 0.35% 77
2015
Q3
$13M Buy
205,353
+7,500
+4% +$535K 0.39% 72
2015
Q2
$14.5M Hold
197,853
0.43% 72
2015
Q1
$12.9M Buy
197,853
+11,400
+6% +$758K 0.39% 75
2014
Q4
$12.1M Hold
186,453
0.43% 74
2014
Q3
$11.2M Hold
186,453
0.41% 74
2014
Q2
$12.9M Buy
186,453
+2,320
+1% +$150K 0.49% 73
2014
Q1
$12M Buy
+184,133
New +$12M 0.49% 74

Other funds holding STJ

ClariVest Asset Management's STJ Position: Q1 2016 in Review

ClariVest Asset Management sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 203,053 shares — an estimated $12.5M sold.

ClariVest Asset Management first reported a position in STJ in Q1 2014 and held it in 8 quarters. The position peaked at $14.5M in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • ClariVest Asset Management reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • ClariVest Asset Management sold 203,053 St Jude Medical shares in Q1 2016, an estimated $12.5M.
  • ClariVest Asset Management first reported a position in St Jude Medical in Q1 2014 and held it in 8 quarters.
  • ClariVest Asset Management's St Jude Medical position peaked at $14.5M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on ClariVest Asset Management's 13F filing for Q1 2016, filed 27 Apr 2016.